Related references
Note: Only part of the references are listed.Hormonal contraception and risk of STIs and bacterial vaginosis in South African adolescents: secondary analysis of a randomised trial
Christina Balle et al.
SEXUALLY TRANSMITTED INFECTIONS (2021)
Clinical trial to evaluate pharmacokinetics and pharmacodynamics of medroxyprogesterone acetate after subcutaneous administration of Depo-Provera
Vera Halpern et al.
FERTILITY AND STERILITY (2021)
An updated review on the effects of depot medroxyprogesterone acetate on the mucosal biology of the female genital tract
Hossaena Ayele et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2021)
Pharmacokinetics, metabolism and serum concentrations of progestins used in contraception
Alexis J. Bick et al.
PHARMACOLOGY & THERAPEUTICS (2021)
Plasma concentration of injectable contraceptive correlates with reduced cervicovaginal growth factor expression in South African women
Refilwe P. Molatlhegi et al.
MUCOSAL IMMUNOLOGY (2020)
Changes in key vaginal bacteria among postpartum African women initiating intramuscular depot-medroxyprogesterone acetate
Bridget M. Whitney et al.
PLOS ONE (2020)
Zim CHIC: A cohort study of immune changes in the female genital tract associated with initiation and use of contraceptives
Sharon L. Achilles et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2020)
Simultaneous assay of segesterone acetate (Nestorone®), estradiol, progesterone, and estrone in human serum by LC-MS/MS
David W. Erikson et al.
CONTRACEPTION (2020)
Vaginal microbiome-hormonal contraceptive interactions associate with the mucosal proteome and HIV acquisition
Laura Noel-Romas et al.
PLOS PATHOGENS (2020)
Hormonal contraception alters vaginal microbiota and cytokines in South African adolescents in a randomized trial
Christina Balle et al.
NATURE COMMUNICATIONS (2020)
Mapping HIV prevalence in sub-Saharan Africa between 2000 and 2017
Laura Dwyer-Lindgren et al.
NATURE (2019)
Medroxyprogesterone acetate concentrations among HIV-infected depot-medroxyprogesterone acetate users receiving antiretroviral therapy in Lilongwe, Malawi
Yasaman Zia et al.
CONTRACEPTION (2019)
HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial
Jared M. Baeten et al.
LANCET (2019)
Cervical and systemic concentrations of long acting hormonal contraceptive (LARC) progestins depend on delivery method: Implications for the study of HIV transmission
Lyndsey R. Buckner et al.
PLOS ONE (2019)
A high resolution LC-MS targeted method for the concomitant analysis of 11 contraceptive progestins and 4 steroids
Csaba Ferenc Laszlo et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2019)
The contraceptive medroxyprogesterone acetate, unlike norethisterone, directly increases R5 HIV-1 infection in human cervical explant tissue at physiologically relevant concentrations
Roslyn M. Ray et al.
SCIENTIFIC REPORTS (2019)
Do metabolites account for higher serum steroid hormone levels measured by RIA compared to mass spectrometry?
Frank Z. Stanczyk et al.
CLINICA CHIMICA ACTA (2018)
Concordance of self-reported hormonal contraceptive use and presence of exogenous hormones in serum among African women
Maria Pyra et al.
CONTRACEPTION (2018)
Misreporting of contraceptive hormone use in clinical research participants
Sharon L. Achilles et al.
CONTRACEPTION (2018)
Discordance between self-reported contraceptive use and detection of exogenous hormones among Malawian women enrolling in a randomized clinical trial
Anuli N. Nwaohiri et al.
CONTRACEPTION (2018)
Simultaneous quantitation of multiple contraceptive hormones in human serum by LC-MS/MS
Steven W. Blue et al.
CONTRACEPTION (2018)
Hormonal Contraception and HIV-1 Acquisition: Biological Mechanisms
Janet P. Hapgood et al.
ENDOCRINE REVIEWS (2018)
Medroxyprogesterone acetate, unlike norethisterone, increases HIV-1 replication in human peripheral blood mononuclear cells and an indicator cell line, via mechanisms involving the glucocorticoid receptor, increased CD4/CD8 ratios and CCR5 levels
Michelle F. Maritz et al.
PLOS ONE (2018)
Medroxyprogesterone acetate levels among Kenyan women using depot medroxyprogesterone acetate in the FEM-PrEP trial
Kavita Nanda et al.
CONTRACEPTION (2016)
The elusive minimum threshold concentration of levonorgestrel for contraceptive efficacy
Ganesh Cherala et al.
CONTRACEPTION (2016)
Changes in Vaginal Microbiota and Immune Mediators in HIV-1-Seronegative Kenyan Women Initiating Depot Medroxyprogesterone Acetate
Alison C. Roxby et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2016)
Medroxyprogesterone acetate and levonorgestrel increase genital mucosal permeability and enhance susceptibility to genital herpes simplex virus type 2 infection
N. E. Quispe Calla et al.
MUCOSAL IMMUNOLOGY (2016)
Differential Glucocorticoid Receptor-Mediated Effects on Immunomodulatory Gene Expression by Progestin Contraceptives: Implications for HIV-1 Pathogenesis
Janet P. Hapgood et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2014)
Subcutaneous DMPA: a better lower dose approach Comment
James D. Shelton et al.
CONTRACEPTION (2014)
Randomized clinical trial of self versus clinical administration of subcutaneous depot medroxyprogesterone acetate
Anitra Beasley et al.
CONTRACEPTION (2014)
A pilot study of depot medroxyprogesterone acetate pharmacokinetics and weight gain in adolescent females
Andrea E. Bonny et al.
CONTRACEPTION (2014)
The Injectable-Only Contraceptive Medroxyprogesterone Acetate, Unlike Norethisterone Acetate and Progesterone, Regulates Inflammatory Genes in Endocervical Cells via the Glucocorticoid Receptor
Yashini Govender et al.
PLOS ONE (2014)
Novel liquid chromatography tandem mass spectrometry (LC-MS/MS) methods for measuring steroids
Brian G. Keevil
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Medroxyprogesterone acetate and estradiol cypionate injectable suspension (Cyclofem) monthly contraceptive injection: steady-state pharmacokinetics
Andrea Thurman et al.
CONTRACEPTION (2013)
The Progestin-Only Contraceptive Medroxyprogesterone Acetate, but Not Norethisterone Acetate, Enhances HIV-1 Vpr-Mediated Apoptosis in Human CD4+ T Cells through the Glucocorticoid Receptor
Michele Tomasicchio et al.
PLOS ONE (2013)
Potential problems with using deuterated internal standards for liquid chromatography-tandem mass spectrometry
A. S. Davison et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2013)
Testosterone measurement by liquid chromatography tandem mass spectrometry: the importance of internal standard choice
L. J. Owen et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2012)
Assessment of androgen concentration in women: liquid chromatography-tandem mass spectrometry and extraction RIA show comparable results
Femi Janse et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
Steroid Profiling by Gas Chromatography–Mass Spectrometry and High Performance Liquid Chromatography–Mass Spectrometry for Adrenal Diseases
Jeffrey G. McDonald et al.
Hormones & Cancer (2011)
Standardization of testosterone measurements in humans
Hubert W. Vesper et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2010)
Advantages and challenges of mass spectrometry assays for steroid hormones
Frank Z. Stanczyk et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2010)
Gas chromatography/mass spectrometry (GC/MS) remains a pre-eminent discovery tool in clinical steroid investigations even in the era of fast liquid chromatography tandem mass spectrometry (LC/MS/MS)
Nils Krone et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2010)
Steroid Hormone Analysis by Tandem Mass Spectrometry
Steven J. Soldin et al.
CLINICAL CHEMISTRY (2009)
Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density
Andrew M. Kaunitz et al.
CONTRACEPTION (2009)
Validation of bioanalytical LC-MS/MS assays: Evaluation of matrix effects
Ann Van Eeckhaut et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2009)
Analysis of conjugated steroid androgens: Deconjugation, derivatisation and associated issues
Rachel L. Gomes et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2009)
Pharmacokinetic interactions between depot medroxyprogesterone acetate and combination antiretroviral therapy
Kavita Nanda et al.
FERTILITY AND STERILITY (2008)
Depo-medroxyprogesterone in women on antiretroviral therapy: Effective contraception and lack of clinically significant interactions
S. E. Cohn et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Pharmacokinetics, ovulation suppression and return to ovulation following a lower dose subcutaneous formulation of Depo-Provera®
J Jain et al.
CONTRACEPTION (2004)
Serum medroxyprogesterone acetate levels in new and repeat users of depot medroxyprogesterone acetate at the end of the dosing interval
J Smit et al.
CONTRACEPTION (2004)
Classification and pharmacology of progestins
AE Schindler et al.
MATURITAS (2003)
The effect upon the human vaginal histology of the long-term use of the injectable contraceptive Depo-Provera
L Bahamondes et al.
CONTRACEPTION (2000)
Share Paper
